news & EVENTS

ExtruMed LLC Announces Appointment of New CFO

June 4, 2007

PLACENTIA, CA — ExtruMed is pleased to announce the appointment of Michael Okada to the position of Chief Financial Officer of ExtruMed. Mike was most recently VP, Finance and Corporate Controller with Clarient, Inc., a leading provider of cancer diagnostic testing services. Prior to that, Mike held senior finance positions with Paciolan, Watson Pharmaceuticals and SM&A. He started his career with the accounting firm Coopers and Lybrand, LLP. Mike is a Certified Public Accountant and received his BS degree in Accounting from Santa Clara University.

"We are very pleased to welcome Mike Okada to the ExtruMed team," commented CEO Bill Ellerkamp. "Mike joins ExtruMed with over 16 years of progressively successful experience in growth-oriented entrepreneurial companies. He brings with him great depth in operational accounting, management systems and controls, financial reporting, financial due diligence, and debt financing."

Okada commented, "I am very pleased to participate in this exciting opportunity.   ExtruMed is a leading player in the precision medical tubing market and has tremendous potential to increase shareholder value through expanding our presence in key geographies and product markets."  

Mike will be joining other members of the ExtruMed team at the upcoming Medical Device Manufacturing exhibition, MDM East, booth #664, at the Jacob Javits Center in New York on June 12-14, 2007.

About ExtruMed
ExtruMed LLC focuses on providing precision tubing solutions for catheter based delivery systems used in minimally invasive, interventional and implantable therapies.  The Company, following the merger in December 2006 of ExtruMed and Extrusioneering, serves a diverse customer base including many of the world's leading medical device OEMs as well as high-profile venture-backed medical device companies.  The Company offers a complete range of tubing services including design, engineering, material selection, prototyping, volume manufacturing, secondary operations and supply chain management. For more information on ExtruMed visit www.extrumed.com.

Contact:

ExtruMed

Bill Ellerkamp
Chief Executive Officer
Tel (714) 993-4100
e-mail: bellerkamp@extrumed.com
Source: ExtruMed, LLC